Related Experiment Video
Updated: Dec 28, 2025
Intracranial Pharmacotherapy and Pain Assays in Rodents
Published on: April 9, 2019
Apomorphine: The Initial Indian Experience in Relation to Response Tests and Pumps
L K Prashanth1,2,3, R Jaychandran2, Raghavendra Seetharam2
1Center for Parkinson's Disease and Movement Disorders Clinic, Bengaluru, Karnataka, India.
Background:
Apomorphine is an option for continuous dopaminergic therapy in Parkinson's disease (PD). However, its effects in varied populations are limited due to its availability.
Objective:
To assess the efficacy and outcomes of apomorphine in Indian patients.
Materials And Methods:
Retrospective analysis of PD patients who underwent apomorphine response test (ART), along with the subset, who went on to apomorphine pumps.
Results:
Twenty-nine confirmed PD patients underwent ART and all PD patients showed good clinical response. 19 subjects developed adverse events which included: nausea (n-15, 51.7%), vomiting (n-10, 34.4%), sleepiness (n-08; 27.5%), yawning (n-07, 24.1%), postural hypotension (n-03, 10.3%), dizziness (n-03, 10.3%), and profuse sweating (n-01, 3.4%). Apomorphine pumps were initiated in six subjects, with significant clinical improvement. Adverse events on pump included subcutaneous nodules, nausea, hypersexuality. Two among them subsequently discontinued the pump primarily due to financial constraints.
Conclusions:
Apomorphine adds up to the armamentarium for treatment of PD patients in India with good clinical responses.
More Related Videos
04:11A Conditioned Place Preference Protocol for Measuring Incubation of Craving in Rats
Published on: November 6, 2018
10:41Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia
Published on: September 12, 2020
Related Concept Videos
01:25Analgesia and Pain Management
01:31Direct-Acting Cholinergic Agonists: Pharmacokinetics
01:11Direct-Acting Cholinergic Agonists: Therapeutic Uses